NPPA invites representation and suggestion on Coronary Stents Ruby Khatun Khatun14 Nov 2017 4:29 PM ISTThrough a recent notification Government of India, Ministry of Chemicals and Fertilizers, Department of Pharmaceuticals, and National Pharmaceutical...
MORE DRUGS added to the Schedule H list Ruby Khatun Khatun9 Nov 2017 11:38 AM ISTThrough a recent gazette notification, Ministry of Health And Family Welfare has extended the list of schedule H drugs by adding more drugs to...
Health ministry releases Mobile APP for ADR reporting, Pharmacovigilance guidelines, Ruby Khatun Khatun6 Oct 2017 4:32 PM ISTNew Delhi: The Secretary, Ministry of Health and Family Welfare, Government of India has launched a mobile app for ADR reporting and pharmacovigilance...
NPPA says Abbott can discontinue Xience Alpine stent in a year, check out details Ruby Khatun Khatun27 Sept 2017 12:42 PM ISTNew Delhi: Through a recent notice, Government of India, Ministry of Chemicals and Fertilizers, Department of Pharmaceuticals, and National...
NPPA allows Abbott to withdraw bioresorbable stent from India Ruby Khatun Khatun22 Sept 2017 5:00 PM ISTNew Delhi: Through a recent notice, Government of India , Ministry of Chemicals and Fertilizers, Department of Pharmaceuticals, and National...
Cannot exceed 8 percent trade margin on Stents: NPPA Ruby Khatun Khatun4 Aug 2017 6:00 PM ISTNew Delhi: NPPA has taken a step ahead to prevent distributors from grabbing higher profits and manipulating trade margins on coronary stents than the...
